Thank you, Mr. Chair.
I want to thank the panel for appearing before the committee.
Natasha Mistry, Canadians face many challenges as we age. I joined the club on May 2. One of these challenges is the increased number of pharmaceutical medicines necessary to improve the quality of life for the elderly. Can you shed some light for the committee on how prescribing practices have changed for elderly Canadians, and outline how some of the vulnerabilities they face could be addressed with a national pharmacare strategy?